Steve D. Thomas

2.0k citations

27 papers · 1.6k indexed · h-index 19

Impact in

Hematology top 2%
- Multiple Myeloma Research and Treatments
Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection

Papers in

Hematology 9
- Multiple Myeloma Research and Treatments 9
Psychiatry and Mental health 7
- Attention Deficit Hyperactivity Disorder 7
- Bipolar Disorder and Treatment 3

Co-authors: David Stirling Steve K. Teo Vikram Khetani Alan M. Hoberman Ratna B. Ray Donald M. Miller Steve Teo Karin A. Kook
Journals: The Journal of Clinical Pharmacology (3 papers)Biopharmaceutics & Drug Disposition (1 paper)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (1 paper)Toxicology (1 paper)Journal of Biochemical and Molecular Toxicology (1 paper)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Steve D. Thomas

27 papers receiving 1.5k citations

Peers

Countries citing papers authored by Steve D. Thomas

Since Specialization

Citations

This map shows the geographic impact of Steve D. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve D. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve D. Thomas more than expected).

Fields of papers citing papers by Steve D. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve D. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve D. Thomas. The network helps show where Steve D. Thomas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steve D. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve D. Thomas Line = papers co-authored together Steve D. Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects The Journal of Clinical Pharmacology ·Steve K. Teo, Karen Malkowski, 朗渋谷, David Stirling, Steve D. Thomas, Daria Stypinski, Vikram Khetani	2004	15
2	Clinical Pharmacokinetics of Thalidomide Clinical Pharmacokinetics ·Steve K. Teo, Wayne A. Colburn, William Tracewell, Karin A. Kook, David Stirling, Majid Butler, O. V. Tytarenko, Steve D. Thomas, Oscar L. Laskin	2004	108
3	Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits Birth Defects Research Part B Developmental and Reproductive Toxicology ·Steve K. Teo, Hae-Ok Kim, David Stirling, Steve D. Thomas, Ingo Bloch, Alan M. Hoberman	2004	16
4	Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats Pharmacology Biochemistry and Behavior ·Steve K. Teo, David Stirling, Steve D. Thomas, Vikram Khetani	2003	28
5	Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline Chirality ·Steve K. Teo, Yong Chen, George W. Muller, Roger S. Chen, Steve D. Thomas, David Stirling, Jaime Ramón Holguín-Peña	2003	23
6	D‐methylphenidate and D,L‐methylphenidate are not developmental toxicants in rats and rabbits Birth Defects Research Part B Developmental and Reproductive Toxicology ·Steve K. Teo, David Stirling, Alan M. Hoberman, Mildred S. Christian, Steve D. Thomas, Vikram Khetani	2003	28
7	d-Methylphenidate is non-genotoxic in in vitro and in vivo assays Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Steve K. Teo, Richard H.C. San, Hillel Soffer, Ramadevi Gudi, David Stirling, Steve D. Thomas, Vikram Khetani	2003	29
8	A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague–Dawley rats Toxicology ·Steve Teo, David Stirling, Steve D. Thomas, Alan M. Hoberman, Anthony L. Kiorpes, Vikram Khetani	2002	297
9	Thalidomide in the treatment of leprosy Microbes and Infection ·Steve K. Teo, D. K. Brown, O. V. Tytarenko, Karin A. Kook, 천예은, David Stirling, Steve D. Thomas	2002	105
10	The perinatal and postnatal toxicity of d-methylphenidate and d,l-methylphenidate in rats Reproductive Toxicology ·Steve K. Teo, David Stirling, Steve D. Thomas, Alan M. Hoberman, Mildred S. Christian, Vikram Khetani	2002	28
11	Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects The Journal of Clinical Pharmacology ·Steve K. Teo, Karen Malkowski, Karin A. Kook, William Tracewell, Wayne A. Colburn, David Stirling, Steve D. Thomas	2001	25
12	Thalidomide is distributed into human semen after oral dosing. PubMed ·Steve K. Teo, Michael A. Haskel, Young-Hoang Chou, Faruq H. Noormohamed, Mike Youle, Margaret Johnson, Barry Peters, David Stirling, Steve D. Thomas	2001	42
13	Thalidomide for the Treatment of AIDS-Associated Wasting AIDS Research and Human Retroviruses ·Gilla Kaplan, Steve D. Thomas, Daniel S. Fierer, Kathleen Mulligan, Patrick Haslett, W. Jeffrey Fessel, Leon G. Smith, Karin A. Kook, David Stirling, Morris Schambelan	2000	67
14	Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen?s disease patients Journal of Biochemical and Molecular Toxicology ·Steve K. Teo, Patrick J. Sabourin, Katherine O’Brien, Karin A. Kook, Steve D. Thomas	2000	58
15	Assessment of the in vitro and in vivo genotoxicity of Thalomid� (thalidomide) Teratogenesis Carcinogenesis and Mutagenesis ·Steve Teo, Michael Morgan, David Stirling, Steve D. Thomas	2000	11
16	Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women Biopharmaceutics & Drug Disposition ·Steve K. Teo, Karen Malkowski, Karin A. Kook, William Tracewell, Wayne A. Colburn, David Stirling, Steve D. Thomas	2000	23
17	Single‐Dose Oral Pharmacokinetics of Three Formulations of Thalidomide in Healthy Male Volunteers The Journal of Clinical Pharmacology ·Steve K. Teo, Wayne A. Colburn, Steve D. Thomas	1999	46
18	S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide Clinical Therapeutics ·Jerome B. Zeldis, Bruce A. Williams, Steve D. Thomas, Ya. G. Smorodinsky	1999	169
19	Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. Journal of Clinical Investigation ·Scott W. Blume, Richard C. Snyder, Ratna B. Ray, Steve D. Thomas, Charles Koller, Donald M. Miller	1991	298
20	Rapid Communication: Mithramycin Selectively Inhibits Transcription Of G-C Containing DNA The American Journal of the Medical Sciences ·Donald M. Miller, Steve D. Thomas, Ratna B. Ray, Jesús Sánchez, Hamid Reza, Maija Karlsson, Carsten Roller	1987	74

About Steve D. Thomas

Steve D. Thomas is a scholar working on Hematology, Psychiatry and Mental health, Genetics, Infectious Diseases and Toxicology, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Attention Deficit Hyperactivity Disorder (7 papers), Leprosy Research and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Bipolar Disorder and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Pharmaceutical studies and practices (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Hematology (428 citations), Pharmacology (149 citations), Genetics (118 citations), Complementary and alternative medicine (90 citations) and Psychiatry and Mental health (147 citations). Steve D. Thomas has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include David Stirling, Steve K. Teo, Vikram Khetani, Alan M. Hoberman, Ratna B. Ray, Donald M. Miller, Steve Teo, Karin A. Kook, Charles Koller and Scott W. Blume. Their work appears in journals such as The Journal of Clinical Pharmacology, Biopharmaceutics & Drug Disposition, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Toxicology and Journal of Biochemical and Molecular Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact